End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with...

The objective of this paper is to further research the already established relationship between economic growth and health by using the results of some previous works and applying them on the recent data, in order to find out if the economic growth rate i

Priority setting and resource allocation across various health care functions is a critical issue in health policy and strategic decision making. As health resources are limited while there are so many health challenges to resolve, consumers and payers have to make difficult decisions about...

Health workforce planning aims to achieve a proper balance between the supply and demand for different categories of health workers, in both the short and longer-term. Workforce planning in the health sector is particularly important, given the time and cost involved in training new doctors and...

ABSTRACT The high price of cancer drugs has become a world-wide phenomenon. In recent decades, studies have produced ample evidence of rising research and clinical testing costs underlying pharmaceutical innovations. There is a general concurrence that the current model of drug development needs...

This is an effort at explaining the reasons and rationale behind the rising mortality rate (CDR) in the South Indian State – Andhra Pradesh. Although the state’s performance in socio-economic sphere seems to be not that impressive, its performance in demographic transition during the last...

Under Medicare Part D, senior citizens choose prescription drug insurance offred by numerous private insurers. We examine non-poor enrollees' actions in 2006 and 2007 using panel data. Our sample reduced overspending by $298 on average, with gains by 81% of them. The greatest improvements were...

This paper analyses possible options how to improve the risk adjustment of the health insurance system in the Czech Republic. From the possible options it argues for including pharmaceutical cost groups (PCGs) as additional risk factors since it is an improvement that can be implemented almost...

Il presente rapporto analizza l'impatto del DL 15/04/2002 n. 63 del Governo Italiano ("Misure per il contenimento della spesa farmaceutica"), con particolare riferimento agli effetti indotti da tali misure sulle decisioni di investimento delle imprese, sulla struttura dell'industria di...

Hospitals hold a special place in the hearts of Canadians as the most visible representation of provinces’ commitment to publicly funded healthcare. As pillars of medicare and the centrepieces of provincial healthcare systems, hospitals are expected to be accessible when Canadians have...